drugset / Trial / NCT00965042

Effect of Ceftobiprole on Human Intestinal Microflora

NCT00965042

Phase 1 Completed 12 enrolled Basilea Pharmaceutica
NaSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to investigate the effect of ceftobiprole treatment on intestinal microflora in healthy volunteers.

Timeline

Start
2009-04
Primary completion
2009-05
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftobiprole Small molecule 500 mg Intravenous

Indications

No indication recorded.